CD44 and prostate cancer: Whereas prostate cancer cell lines cultured under long-term monolayer culture conditions contain less than 2% prostate cancer progenitors, this CD133+/CD44+ cancer progenitor population can be expanded under anchorage independent serum-free conditions (sphere forming conditions) [5], [11].